Anupam Rasayan India Ltd Stock

Stocks

ANURAS

INE930P01018

Specialty Chemicals

Market Closed - NSE India S.E. 09:05:07 17/07/26 pm AEST 5-day change 1st Jan Change
1,267.50 INR -0.12% Intraday chart for Anupam Rasayan India Ltd -0.04% -3.90%

Valuation: Anupam Rasayan India Ltd

Market Cap 144B 1.5B 1.31B 1.21B 1.11B 2.1B 2.15B 14.44B 5.68B 70.67B 5.63B 5.5B 243B P/E 2026
81.6x
P/E 2027 * 42.8x
Enterprise Value 149B 1.55B 1.36B 1.25B 1.15B 2.17B 2.22B 14.96B 5.88B 73.2B 5.83B 5.7B 252B EV / Sales 2026
6.55x
EV / Sales 2027 * 4.36x
Free-Float
16.12%
Yield 2026
0.12%
Yield 2027 * 0.16%
15/07 Anupam Rasayan India Limited Signs Letter Of Intent With BASQUEVOLT, S.A. For Potential Long-Term Supply Of Specialty Chemical Product Worth USD 300 Million CI
06/07 Tanfac Industries Limited announced that it expects to receive INR 1.734872962 billion in funding from Anupam Rasayan India Ltd, Alrox Enterprises Private Limited CI
12/06 Anupam Rasayan India Limited Commercialises ETFA Using Flow Chemistry CI
04/06 Crisil Places Anupam Rasayan Ratings on Watch Developing After Bliss GVS Acquisition Announcement MT
25/05 Anupam Rasayan India Ltd, Q4 2026 Earnings Call, May 25, 2026
24/05 Anupam Rasayan India Ltd Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026 CI
24/05 Anupam Rasayan India Limited Announces Resignation of Vishal Thakkar as Deputy Chief Financial Officer and Key Managerial Personnel, Effective May 23, 2026 CI
24/05 Anupam Rasayan India Ltd Recommends Final Dividend for the Financial Year 2025-26 CI
23/05 Anupam Rasayan India Ltd proposed to acquire 26.21% stake in Bliss GVS Pharma Limited for INR 8.3 billion. CI
23/05 Anupam Rasayan India Ltd proposed to acquire 26.21% stake in Bliss GVS Pharma Limited for INR 8.3 billion. CI
23/05 Anupam Rasayan India Ltd entered into a share purchase agreement to acquire 43.30% stake in Bliss GVS Pharma Limited for INR 13.7 billion. CI
28/02 Anupam Rasayan India Ltd completed the acquisition of Jayhawk Fine Chemicals Corporation from CABB Group GmbH. CI
16/02 Anupam Rasayan India's Consolidated Profit Rises in Fiscal Q3 MT
1 day-0.12%
1 week-0.04%
Current month+0.25%
1 month-0.75%
3 months-1.59%
6 months-2.98%
Current year-3.90%
1 week 1,256
Extreme 1256
1,286.4
1 month 1,249
Extreme 1249
1,297.5
Current year 1,162.3
Extreme 1162.3
1,415
1 year 1,045.2
Extreme 1045.2
1,415
3 years 601
Extreme 601
1,415
5 years 546.75
Extreme 546.75
1,415
10 years 474
Extreme 474
1,415
Manager TitleAgeSince
Chief Executive Officer - 11/09/2023
Director of Finance/CFO 36 15/03/2022
Chief Operating Officer 54 23/02/2021
Director TitleAgeSince
Chairman 50 23/04/2013
Director/Board Member 52 01/01/1992
Chairman 77 31/08/2020
Change 5-day change 1-year change 3-year change Capi.($)
-0.12%-0.04%+10.22%+27.84% 1.5B
-1.04%-0.54%+1.52%+45.68% 76.78B
+0.56%-0.32%-9.76%+15.10% 39.16B
-0.88%-2.67%-21.66%-38.20% 31.51B
+0.25%+1.31%+20.74%+31.41% 26.53B
+0.07%+6.52%+19.12%+8.34% 22.04B
+5.25%-4.62%+80.48%-12.53% 19.94B
+0.74%+0.45%-40.31%-40.00% 18.27B
+1.10%-4.18%+56.71%-48.06% 14.24B
-0.89%+0.05%-0.76%-8.62% 13.9B
Average +0.50%-0.40%+11.63%-1.90% 26.39B
Weighted average by Cap. +0.17%-0.39%+6.46%+8.22%

Financials

2026 2027 *
Net sales 22.24B 231M 202M 186M 172M 324M 331M 2.23B 875M 10.89B 867M 848M 37.49B 37.23B 387M 338M 312M 287M 542M 554M 3.73B 1.47B 18.23B 1.45B 1.42B 62.77B
Net income 1.59B 16.5M 14.42M 13.31M 12.26M 23.12M 23.63M 159M 62.55M 778M 61.97M 60.61M 2.68B 3.37B 34.98M 30.57M 28.21M 26M 49.01M 50.1M 337M 133M 1.65B 131M 128M 5.68B
Net Debt 5.16B 53.57M 46.82M 43.2M 39.82M 75.05M 76.72M 516M 203M 2.53B 201M 197M 8.7B 18.21B 189M 165M 152M 141M 265M 271M 1.82B 717M 8.92B 710M 694M 30.7B
Logo Anupam Rasayan India Ltd
Anupam Rasayan India Ltd. is an India-based company, which is engaged in the custom synthesis (CSM) and manufacturing of specialty chemicals. The Company's segments include Life Science related Specialty Chemicals and Other Specialty Chemicals. The Life Science related Specialty Chemicals segment includes agrochemicals (including crop protection), personal care, and pharmaceuticals businesses. Its agrochemicals business includes manufacturing agro intermediates and active ingredients, such as insecticides, fungicides, herbicides and plant growth regulators. Its personal care business manufactures antibacterial and ultraviolet protection intermediates. Its pharmaceuticals business develops intermediates and key starting materials for active pharmaceutical ingredients used in therapeutic segments, including cardiovascular and antidiabetic. The Other Specialty Chemicals segment includes specialty pigments, specialty dyes, and polymer additives. It caters to Indian and global customers.
Employees
2,606
Date Price Change Volume
17/07/26 INR 1,267.50 -0.12% 123,952
16/07/26 INR 1,269.00 +0.09% 317,027
15/07/26 INR 1,267.80 +0.32% 593,884
14/07/26 INR 1,263.80 -0.46% 1,047,172
13/07/26 INR 1,269.70 +0.13% 2,304,055
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
7
Last Close Price
1,267.50INR
Average target price
1,143.00INR
Spread / Average Target
-9.82%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ANURAS Stock